Exploring Three High Growth Tech Stocks In The United States

Simply Wall St.
25 Feb

Over the last 7 days, the United States market has experienced a 3.0% decline, though it remains up by 18% over the past year with earnings forecasted to grow annually by 14%. In this context of fluctuating yet promising growth, identifying high growth tech stocks requires careful consideration of their potential for innovation and scalability in alignment with broader market trends.

Top 10 High Growth Tech Companies In The United States

Name Revenue Growth Earnings Growth Growth Rating
Super Micro Computer 29.79% 27.57% ★★★★★★
Travere Therapeutics 28.04% 65.55% ★★★★★★
Alkami Technology 21.99% 102.65% ★★★★★★
AVITA Medical 27.78% 55.33% ★★★★★★
TG Therapeutics 29.48% 45.20% ★★★★★★
Bitdeer Technologies Group 51.85% 122.52% ★★★★★★
Clene 61.16% 59.11% ★★★★★★
Alnylam Pharmaceuticals 22.67% 58.73% ★★★★★★
Alvotech 31.17% 100.18% ★★★★★★
Lumentum Holdings 21.24% 119.37% ★★★★★★

Click here to see the full list of 227 stocks from our US High Growth Tech and AI Stocks screener.

Here's a peek at a few of the choices from the screener.

Exact Sciences

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Exact Sciences Corporation is engaged in the development and commercialization of cancer screening and diagnostic test products, with a market capitalization of approximately $9.15 billion.

Operations: The company generates revenue primarily from its biotechnology segment, which contributed $2.76 billion. It focuses on cancer screening and diagnostic test products both domestically and internationally.

Exact Sciences, navigating through a challenging landscape marked by unprofitability, is poised for significant shifts with an expected revenue growth of 9.5% per year, outpacing the US market's 8.8%. Despite a substantial net loss of $864.59 million in Q4 2024, up from $49.77 million the previous year, the firm is optimistic about its future financial health, projecting annual revenues between $3.025 billion and $3.085 billion for 2025. This growth trajectory is supported by robust investments in R&D and strategic M&A activities aimed at enhancing its product offerings and market position in precision oncology and screening segments.

  • Delve into the full analysis health report here for a deeper understanding of Exact Sciences.
  • Evaluate Exact Sciences' historical performance by accessing our past performance report.

NasdaqCM:EXAS Earnings and Revenue Growth as at Feb 2025

Bel Fuse

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Bel Fuse Inc. designs, manufactures, markets, and sells products that power, protect, and connect electronic circuits with a market capitalization of approximately $1.08 billion.

Operations: Bel Fuse Inc. generates revenue through three primary segments: Power Solutions and Protection, Connectivity Solutions, and Magnetic Solutions, with the Power Solutions and Protection segment contributing $245.55 million. The company's focus on designing and manufacturing electronic components allows it to serve a diverse range of industries by providing essential products that ensure the functionality of electronic circuits.

Bel Fuse, amidst a transformative leadership shift, is poised to leverage its robust product foundation and strategic financial discipline under new CEO Farouq Tuweiq. With an 11.9% forecasted annual revenue growth outpacing the US market's 8.8%, and a significant earnings growth projection of 22.9% per year, the company demonstrates strong potential in the electronics sector. This outlook is further supported by R&D investments aimed at innovation and quality enhancements, crucial for sustaining competitive advantage in rapidly evolving tech landscapes. Recent dividend affirmations underscore Bel's commitment to shareholder returns despite challenging industry dynamics and a high debt level that warrants cautious financial management moving forward.

  • Click here and access our complete health analysis report to understand the dynamics of Bel Fuse.
  • Understand Bel Fuse's track record by examining our Past report.

NasdaqGS:BELF.A Revenue and Expenses Breakdown as at Feb 2025

Super Micro Computer

Simply Wall St Growth Rating: ★★★★★★

Overview: Super Micro Computer, Inc. develops and manufactures high performance server and storage solutions using modular and open architecture for a global market, with a market cap of approximately $32.83 billion.

Operations: Super Micro Computer, Inc. generates revenue primarily from developing and providing high-performance server solutions, amounting to approximately $14.94 billion annually. The company operates across the United States, Europe, Asia, and other international markets.

Super Micro Computer, Inc. (SMCI) is outpacing its sector with a remarkable 88.8% earnings growth over the last year, significantly higher than the tech industry's average of 40.6%. This surge is underpinned by robust demand for its AI data center solutions, notably those utilizing NVIDIA's Blackwell platform which promises up to 15x inference and 3x training performance improvements. Despite facing challenges like delayed SEC filings and a recent exclusion from the NASDAQ-100 index, SMCI’s forward-looking guidance anticipates strong sales growth between $23.5 billion to $25 billion for fiscal year 2025, reflecting its strategic focus on high-performance computing and AI technologies.

  • Click to explore a detailed breakdown of our findings in Super Micro Computer's health report.
  • Assess Super Micro Computer's past performance with our detailed historical performance reports.

NasdaqGS:SMCI Earnings and Revenue Growth as at Feb 2025

Where To Now?

  • Delve into our full catalog of 227 US High Growth Tech and AI Stocks here.
  • Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.
  • Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.

Interested In Other Possibilities?

  • Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
  • Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
  • Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include NasdaqCM:EXAS NasdaqGS:BELF.A and NasdaqGS:SMCI.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10